{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mastocytose cutanée : Questions médicales les plus fréquentes",
"headline": "Mastocytose cutanée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mastocytose cutanée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-04",
"dateModified": "2025-05-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mastocytose cutanée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mastocytose",
"url": "https://questionsmedicales.fr/mesh/D008415",
"about": {
"@type": "MedicalCondition",
"name": "Mastocytose",
"code": {
"@type": "MedicalCode",
"code": "D008415",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.762.750"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mastocytome cutané",
"alternateName": "Mastocytoma, Skin",
"url": "https://questionsmedicales.fr/mesh/D054705",
"about": {
"@type": "MedicalCondition",
"name": "Mastocytome cutané",
"code": {
"@type": "MedicalCode",
"code": "D054705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.762.750.563.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Urticaire pigmentaire",
"alternateName": "Urticaria Pigmentosa",
"url": "https://questionsmedicales.fr/mesh/D014582",
"about": {
"@type": "MedicalCondition",
"name": "Urticaire pigmentaire",
"code": {
"@type": "MedicalCode",
"code": "D014582",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.762.750.563.850"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Mastocytose cutanée",
"alternateName": "Mastocytosis, Cutaneous",
"code": {
"@type": "MedicalCode",
"code": "D034701",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Magdalena Lange",
"url": "https://questionsmedicales.fr/author/Magdalena%20Lange",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, 80-211 Gdańsk, Poland."
}
},
{
"@type": "Person",
"name": "Karin Hartmann",
"url": "https://questionsmedicales.fr/author/Karin%20Hartmann",
"affiliation": {
"@type": "Organization",
"name": "Allergologische Poliklinik, Klinik für Dermatologie, Universitätsspital Basel, Petersgraben 4, 4031, Basel, Schweiz. karin.hartmann@usb.ch."
}
},
{
"@type": "Person",
"name": "Knut Brockow",
"url": "https://questionsmedicales.fr/author/Knut%20Brockow",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology and Allergy Biederstein, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany."
}
},
{
"@type": "Person",
"name": "Roman J Nowicki",
"url": "https://questionsmedicales.fr/author/Roman%20J%20Nowicki",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, 80-211 Gdańsk, Poland."
}
},
{
"@type": "Person",
"name": "Olivier Hermine",
"url": "https://questionsmedicales.fr/author/Olivier%20Hermine",
"affiliation": {
"@type": "Organization",
"name": "Department of Hematology and Mastocytosis Expert Centre (CEREMAST), Necker Children's Hospital and Paris Descartes University, Assistance Publique Hôpitaux de Paris, Paris, France. Electronic address: ohermine@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Problem-Based Learning to Encourage Active Learning and Teamwork Among First Year Medical Students - Student Reports in 2020 - What is the Best Response When Listeners Fail to Hear English Correctly? (Course name: Listening Skills: Development and Assessment).",
"datePublished": "2022-11-18",
"url": "https://questionsmedicales.fr/article/39081384",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14789/jmj.JMJ21-0054-OT"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between the starting age of non-parental Early Childhood Education and Care (ECEC), and psycho-social problems in adolescence in West and East Germany - a natural experiment using data from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).",
"datePublished": "2023-11-20",
"url": "https://questionsmedicales.fr/article/37986110",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40359-023-01447-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Importance of most frequent needs of the disabled in shaping areas of support in public health. Part. II. Disability as a consequence of dysfunction in the state of health disrupting daily functioning based on selected health and socio-demographic characteristics - interdisciplinary problems in the domain of public health.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36583315",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.26444/aaem/158547"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Strengths and Difficulties Questionnaire Is of Clinical Significance Regarding Emotional and Behavioral Problems in 7-Year-Old Children With Familial Risk of Schizophrenia or Bipolar Disorder and Population-Based Controls the Danish High Risk and Resilience Study-VIA 7; A Population-Based Cohort Study.",
"datePublished": "2022-05-25",
"url": "https://questionsmedicales.fr/article/35693960",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpsyt.2022.861219"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study protocol for an adaptive, multi-arm, multi-stage (MAMS) randomised controlled trial of brief remotely delivered psychosocial interventions for people with serious mental health problems who have experienced a recent suicidal crisis: Remote Approaches to Psychosocial Intervention Delivery (RAPID).",
"datePublished": "2024-07-06",
"url": "https://questionsmedicales.fr/article/38971788",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-024-08293-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles de l'activation mastocytaire",
"item": "https://questionsmedicales.fr/mesh/D000090362"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mastocytose",
"item": "https://questionsmedicales.fr/mesh/D008415"
},
{
"@type": "ListItem",
"position": 5,
"name": "Mastocytose cutanée",
"item": "https://questionsmedicales.fr/mesh/D034701"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mastocytose cutanée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mastocytose cutanée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mastocytose cutanée",
"description": "Comment diagnostique-t-on la mastocytose cutanée ?\nQuels tests sont utilisés pour confirmer la mastocytose ?\nLes symptômes sont-ils suffisants pour le diagnostic ?\nLa mastocytose cutanée est-elle confondue avec d'autres maladies ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=Problem+Solving&page=779#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mastocytose cutanée",
"description": "Quels sont les symptômes courants de la mastocytose cutanée ?\nLa mastocytose cutanée provoque-t-elle des douleurs ?\nLes symptômes varient-ils d'une personne à l'autre ?\nY a-t-il des symptômes systémiques associés ?\nLes lésions cutanées sont-elles contagieuses ?",
"url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=Problem+Solving&page=779#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mastocytose cutanée",
"description": "Peut-on prévenir la mastocytose cutanée ?\nLes allergènes peuvent-ils aggraver la condition ?\nFaut-il éviter certains médicaments ?\nL'évitement du stress aide-t-il ?\nLes soins de la peau sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=Problem+Solving&page=779#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mastocytose cutanée",
"description": "Quels traitements sont disponibles pour la mastocytose cutanée ?\nLes antihistaminiques sont-ils efficaces ?\nLa photothérapie est-elle une option de traitement ?\nLes traitements sont-ils permanents ?\nDes traitements alternatifs existent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=Problem+Solving&page=779#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mastocytose cutanée",
"description": "Quelles complications peuvent survenir avec la mastocytose cutanée ?\nLa mastocytose cutanée peut-elle évoluer vers une forme plus grave ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=Problem+Solving&page=779#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mastocytose cutanée",
"description": "Quels sont les facteurs de risque de la mastocytose cutanée ?\nL'âge joue-t-il un rôle dans la mastocytose cutanée ?\nLes femmes sont-elles plus touchées que les hommes ?\nLes maladies auto-immunes augmentent-elles le risque ?\nL'exposition à des produits chimiques est-elle un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D034701?mesh_terms=Problem+Solving&page=779#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la mastocytose cutanée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et la biopsie cutanée pour détecter les mastocytes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer la mastocytose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins pour mesurer les niveaux de tryptase peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils suffisants pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes doivent être corroborés par des examens histologiques."
}
},
{
"@type": "Question",
"name": "La mastocytose cutanée est-elle confondue avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres affections cutanées comme l'urticaire."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des antécédents d'allergies ou d'autres maladies liées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la mastocytose cutanée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des démangeaisons, des rougeurs et des lésions cutanées."
}
},
{
"@type": "Question",
"name": "La mastocytose cutanée provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des douleurs localisées, surtout en cas de lésions étendues."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme des nausées peuvent survenir dans certains cas."
}
},
{
"@type": "Question",
"name": "Les lésions cutanées sont-elles contagieuses ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les lésions cutanées de la mastocytose ne sont pas contagieuses."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la mastocytose cutanée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique pour la mastocytose cutanée."
}
},
{
"@type": "Question",
"name": "Les allergènes peuvent-ils aggraver la condition ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains allergènes peut aggraver les symptômes."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains médicaments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent déclencher des réactions chez les patients sensibles."
}
},
{
"@type": "Question",
"name": "L'évitement du stress aide-t-il ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gérer le stress peut aider à réduire les poussées de symptômes chez certains patients."
}
},
{
"@type": "Question",
"name": "Les soins de la peau sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins appropriés de la peau peuvent aider à minimiser les irritations."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la mastocytose cutanée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des antihistaminiques et des corticostéroïdes topiques."
}
},
{
"@type": "Question",
"name": "Les antihistaminiques sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à réduire les démangeaisons et les rougeurs."
}
},
{
"@type": "Question",
"name": "La photothérapie est-elle une option de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la photothérapie peut être utilisée pour traiter les lésions cutanées."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils permanents ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les traitements visent à gérer les symptômes, pas à guérir la maladie."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines personnes explorent des traitements alternatifs, mais leur efficacité n'est pas prouvée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la mastocytose cutanée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections cutanées peuvent survenir en raison de lésions."
}
},
{
"@type": "Question",
"name": "La mastocytose cutanée peut-elle évoluer vers une forme plus grave ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans de rares cas, elle peut évoluer vers une mastocytose systémique."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications ne sont pas fréquentes mais peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite souvent une consultation spécialisée."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent affecter la qualité de vie en raison de l'inconfort."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la mastocytose cutanée ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux et des allergies cutanées."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans la mastocytose cutanée ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la mastocytose cutanée est plus fréquente chez les enfants et les jeunes adultes."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus touchées que les hommes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la mastocytose cutanée affecte les hommes et les femmes de manière égale."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de mastocytose."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques est-elle un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains produits chimiques peut être un facteur de risque."
}
}
]
}
]
}
This study was aimed at investigating the best way to seek clarification when failing to correctly understand the meaning of an English utterance....
We administered a survey to Japanese freshmen majoring in medicine to determine the main reasons for their failure to hear utterances and how they seek clarification when facing different situations o...
Generally, the students obtained a low percentage of correct answers to multiple-choice questions. The use of a particular test-taking strategy depended primarily on an individual, but the students ev...
The current study revealed that the most common causes of mishearing among the participants were a lack of vocabulary and speech speed. The most popular strategy for seeking clarification was asking f...
The study aimed to investigate the association between the start age of non-parental Early Childhood Education and Care (ECEC) and psycho-social problems in adolescence. The similarities and differenc...
Our sample consisted of 1022 children (621 from West Germany, 401 from East Germany) aged 3-4 years at wave 2003-2006 that were followed up to wave 2014-2017 as adolescents (mean ± SD age = 14.4 ± 0.0...
Those who started ECEC between 2 and 3 years old (reference) had the lowest scores of psycho-social problems in the whole Germany and in West Germany in adolescence. In comparison, those who started E...
The results suggest that if children start ECEC older than 3 years or younger than 2 years, more attention needs to be given to internalizing or externalizing psycho-social problems respectively. The ...
The disabled are a group with heterogeneous structure of causes and needs. Assessment of these causes and needs requires prospective studies in order to use the results within public health actions, i...
The examined population were 676 disabled aged from 19-98, including 56.4% of females, and 43,6% of males; rural inhabitants constituted 38.0%. The study was conducted by the method of purposive sampl...
The most frequently occurring problems were material difficulties, lack of rehabilitation in the place of residence, hindered access to a physician, difficulties with settling official matters, loneli...
The majority of the problems hindering daily life of the disabled fell within social rather than medical categories. Age, level of education, degree of disability, legal status, and material standard ...
Children born to parents with severe mental illness are at increased risk of mental and behavioral difficulties during childhood. We aimed to investigate the occurrence of clinically significant behav...
By means of the Danish National Registers, we established a cohort of 522 7-year old children stratified by familial high risk for schizophrenia spectrum disorder (...
Children with familial high risk of schizophrenia spectrum disorder or bipolar disorder have a significantly increased risk (OR = 3.8 and 2.3) of suffering clinically significant behavioral difficulti...
People with serious mental health problems (SMHP) are more likely to be admitted to psychiatric hospital following contact with crisis services. Admissions can have significant personal costs, be trau...
A multi-stage, multi-arm (MAMS) randomised controlled trial (RCT) with four arms conducted over two stages to determine the clinical and cost effectiveness of three psychosocial treatments, compared t...
There is a need for evidence-based interventions to reduce psychiatric admissions, via reduction of suicidality. Our focus on remote delivery of established brief psychosocial interventions, utilisati...
ISRCTN33079589. Registered on June 20, 2022....
In the context of COVID-19, NHS Child and Adolescent Mental Health Services (CAMHS) and other children's mental health services have faced major challenges in providing psychological treatments that (...
We will conduct a two-arm, multi-site, randomised controlled non-inferiority trial to evaluate the clinical and cost-effectiveness of OSI with therapist support compared to CAMHS and other child menta...
If non-inferiority is shown, the research will provide (1) a solution for efficient psychological treatment for child anxiety disorders while social distancing (for the COVID-19 context and future pan...
ISRCTN ISRCTN12890382 . Registered prospectively on 23 October 2020....
Mental health recovery narratives are a first-hand account of an individual's recovery from mental health distress, access to narratives can aid recovery. The NEON Intervention is a web-application pr...
The NEON Intervention is assessed in two trial populations, one for people with experience of psychosis in the last 5 years, and mental health distress in the last six months (NEON Trial) and one for ...
The primary outcome is the mean score of subjective items on the Manchester Short Assessment of Quality-of-Life questionnaire (MANSA) at 52 weeks. Secondary outcomes are scores from the Herth Hope Ind...
This manuscript is the statistical analysis plan (SAP) for the NEON trials. Any post hoc analysis, such as those requested by journal reviewers will be clearly labelled as such in the final trial repo...
Around 10% of school-aged children experience mental health difficulties. Many more are 'vulnerable': experiencing emotional and/or behavioural problems reaching clinical levels, and thus at greatest ...
The "CUES for Schools" study is a multicentre cluster randomised controlled trial in primary schools in south east England. Schools will be randomised to receive the usual school curriculum, or the CU...
The study will show whether CUES for schools is more effective than the usual curriculum in reducing emotional and behavioural problems in vulnerable Year 4 children, and thus reducing the risk of men...
Trial Registration ISRCTN11445338. Registered on September 12, 2022....